Kroeger Christopher A. 4
4 · Millendo Therapeutics, Inc. · Filed Dec 11, 2018
Insider Transaction Report
Form 4
Kroeger Christopher A.
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-10+47,666→ 47,666 totalExercise: $13.98Exp: 2028-05-10→ Common Stock (47,666 underlying)
Footnotes (2)
- [F1]Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.
- [F2]The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause).